Fierce Biotech Names Proxygen a “Fierce 15” Biotech Company of 2023

VIENNA, Austria, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Proxygen, a leader in the discovery and development of molecular glue degraders, today announced that Fierce Biotech has named it as one of 2023’s “Fierce 15” biotechnology companies. The annual special report features the most innovative and promising early-stage biotechnology companies in the industry. “It is an incredible honor to be recognized as one of the Fierce 15 biotech companies for 2023,” said Bernd Boidol, Ph.D., chief executive offi

Chris Jenkins on LinkedIn: #goteam #ibc #irb

Mark Federici on LinkedIn: Fierce Biotech Names Proxygen a “Fierce

Proxygen LinkedIn

Fierce Life Sciences Events on LinkedIn: Fierce Clinical Summit

Jacob Perrett posted on LinkedIn

Fierce Life Sciences Events on LinkedIn: The Future of Biotech

见时知几：2023年Fierce15药企预示着哪些投资趋势- 知乎

Jacob Perrett on LinkedIn: VC funding update: Which Boston-area

Fierce Life Sciences Events on LinkedIn: Fierce Clinical Summit

Mark Federici on LinkedIn: Fierce Biotech Names Proxygen a “Fierce

見時知幾：2023 年Fierce15 藥企預示着哪些投資趨勢- LongPort

Chris Jenkins on LinkedIn: Introducing Fierce Biotech's 2023 Fierce 15

Mark Federici on LinkedIn: Fierce Biotech Names Proxygen a “Fierce

见时知几：2023年Fierce15药企预示着哪些投资趋势- 知乎